A detailed history of Longbow Finance Sa transactions in Abbott Laboratories stock. As of the latest transaction made, Longbow Finance Sa holds 76,518 shares of ABT stock, worth $8.74 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
76,518
Previous 76,518 -0.0%
Holding current value
$8.74 Million
Previous $7.95 Billion 9.72%
% of portfolio
0.93%
Previous 0.82%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$100.73 - $112.44 $400,804 - $447,398
-3,979 Reduced 4.94%
76,518 $7.95 Billion
Q1 2024

Apr 30, 2024

SELL
$109.52 - $120.96 $855,789 - $945,181
-7,814 Reduced 8.85%
80,497 $9.15 Billion
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $364,457 - $446,126
4,041 Added 4.8%
88,311 $9.72 Billion
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $27,703 - $33,239
-290 Reduced 0.34%
84,270 $8.16 Billion
Q2 2023

Nov 13, 2023

BUY
$100.78 - $112.29 $8.52 Million - $9.5 Million
84,560 New
84,560 $9.22 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Longbow Finance Sa Portfolio

Follow Longbow Finance Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longbow Finance Sa, based on Form 13F filings with the SEC.

News

Stay updated on Longbow Finance Sa with notifications on news.